PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
28-Dec-2020 Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation 3 Seasons Capital LLC
28-Dec-2020 DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm The Schall Law Firm
28-Dec-2020 Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1 Alligator Bioscience
28-Dec-2020 Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe Elevar Therapeutics
28-Dec-2020 Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe Elevar Therapeutics
28-Dec-2020 Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma Innovent Biologics, Inc.
28-Dec-2020 Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma Innovent Biologics, Inc.
25-Dec-2020 Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potentially brings more benefits to patients Arctic Vision
24-Dec-2020 INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine INOVIO Pharmaceuticals, Inc.
23-Dec-2020 FDA authorizes marketing of new device designed to remove dead pancreatic tissue U.S. Food and Drug Administration
23-Dec-2020 MaxCyte to exceed 2020 Full Year market expectations MaxCyte
23-Dec-2020 Amryt Granted Orphan Drug Designation by the FDA for AP103 Amryt
23-Dec-2020 Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation Novadip Biosciences
23-Dec-2020 CURRANZ AWARDED TWO ACCOLADES AT THE EUROPEAN SPECIALIST SPORTS NUTRITION ALLIANCE AWARDS 2020 CurraNZ
23-Dec-2020 UPM Biochemicals grows lignin business with new Domtar supply agreement UPM Biochemicals
23-Dec-2020 The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition PharmaNutra S.p.A.
23-Dec-2020 Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma Rakuten Medical, Inc.
23-Dec-2020 BioInvent receives $3 million payment related to selection of antibodies under collaboration with Pfizer Inc. BioInvent
22-Dec-2020 Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR" Pharming Group N.V.
22-Dec-2020 FDA Warns Companies Illegally Selling CBD Products U.S. Food and Drug Administration